Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Hermansky Pudlak syndrome 2


Other Names for this Disease

  • Hermansky-Pudlak syndrome 2
  • HPS2
  • Platelet defects and oculocutaneous albinism
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Management Guidelines

  • GeneReviews provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions. Click on the link to view the article on this topic.

Clinical Trials & Research for this Disease

  • ClinicalTrials.gov lists trials that are studying or have studied Hermansky Pudlak syndrome 2. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
  • The┬áRare Lung Diseases Consortium: Molecular Pathway-Driven Diagnostics and Therapeutics for Rare Lung Diseases is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research involving pulmonary alveolar proteinosis, Hermansky-Pudlak Syndrome, and Lymphangioleiomyomatosis. A pilot project program supports research into other rare lung diseases that complement the main research projects.

Other Names for this Disease
  • Hermansky-Pudlak syndrome 2
  • HPS2
  • Platelet defects and oculocutaneous albinism
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.